Total Payments
$1,011
2023 Payments
$17.19
Companies
12
Transactions
54
Medicare Patients
888
Medicare Billing
$129,526
Payment Breakdown by Category
Food & Beverage$957.33 (94.7%)
Other$53.53 (5.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $957.33 | 51 | 94.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53.53 | 3 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARBOR PHARMACEUTICALS, INC. | $249.14 | 15 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $170.26 | 8 | $0 (2019) |
| AbbVie Inc. | $109.31 | 6 | $0 (2023) |
| Amgen Inc. | $94.75 | 4 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $92.55 | 5 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $85.48 | 6 | $0 (2018) |
| Impax Laboratories, Inc. | $70.21 | 3 | $0 (2018) |
| Acorda Therapeutics, Inc | $53.53 | 3 | $0 (2019) |
| SI-BONE, Inc. | $25.78 | 1 | $0 (2019) |
| ASSERTIO THERAPEUTICS, Inc. | $25.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.19 | 1 | AbbVie Inc. ($17.19) |
| 2022 | $62.12 | 3 | ABBVIE INC. ($62.12) |
| 2021 | $30.00 | 2 | AbbVie Inc. ($30.00) |
| 2019 | $386.66 | 20 | ARBOR PHARMACEUTICALS, INC. ($169.31) |
| 2018 | $236.84 | 14 | ARBOR PHARMACEUTICALS, INC. ($79.83) |
| 2017 | $278.05 | 14 | Avanir Pharmaceuticals, Inc. ($75.82) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/14/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/28/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/29/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/12/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Sleep | ||||||
| 11/21/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Sleep | ||||||
| 10/28/2019 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 10/17/2019 | ASSERTIO THERAPEUTICS, Inc. | Gralise (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neurology | ||||||
| 09/26/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Sleep | ||||||
| 09/24/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/05/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Sleep | ||||||
| 08/13/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 08/08/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Sleep | ||||||
| 07/25/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Sleep | ||||||
| 06/13/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Sleep | ||||||
| 05/21/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Neuroscience | ||||||
| 05/09/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Neuroscience | ||||||
| 05/06/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 04/23/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Sleep | ||||||
| 03/20/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Sleep | ||||||
| 02/19/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $18.18 | General |
| Category: PARKINSONS DISEASE | ||||||
| 02/14/2019 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Sleep | ||||||
| 01/31/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 180 | 435 | $40,196 | $29,885 |
| 2022 | 5 | 202 | 456 | $43,994 | $34,079 |
| 2021 | 8 | 277 | 699 | $51,562 | $40,431 |
| 2020 | 8 | 229 | 442 | $32,497 | $25,131 |
Total Patients
888
Total Services
2,032
Medicare Billing
$129,526
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 199 | $21,275 | $15,867 | 74.6% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2023 | 52 | 135 | $11,241 | $8,466 | 75.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 47 | 47 | $4,059 | $2,852 | 70.3% |
| 98927 | Osteopathic manipulative treatment, 5-6 body regions | Office | 2023 | 21 | 54 | $3,621 | $2,701 | 74.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 194 | $21,290 | $16,569 | 77.8% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2022 | 57 | 143 | $12,162 | $9,388 | 77.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 48 | 48 | $4,295 | $3,255 | 75.8% |
| 98927 | Osteopathic manipulative treatment, 5-6 body regions | Office | 2022 | 29 | 55 | $3,798 | $2,944 | 77.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 16 | $2,449 | $1,923 | 78.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 232 | $25,571 | $20,115 | 78.7% |
| 98928 | Osteopathic manipulative treatment to 7-8 body regions | Office | 2021 | 64 | 134 | $11,181 | $8,744 | 78.2% |
| 98927 | Osteopathic manipulative treatment to 5-6 body regions | Office | 2021 | 35 | 102 | $7,058 | $5,588 | 79.2% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 51 | 51 | $4,558 | $3,432 | 75.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 31 | $2,102 | $1,682 | 80.0% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 11 | 13 | $889.46 | $711.62 | 80.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 19 | 125 | $157.23 | $125.38 | 79.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 11 | $45.00 | $33.00 | 73.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 139 | $12,509 | $9,774 | 78.1% |
| 98928 | Osteopathic manipulative treatment to 7-8 body regions | Office | 2020 | 40 | 82 | $6,971 | $5,344 | 76.7% |
| 98927 | Osteopathic manipulative treatment to 5-6 body regions | Office | 2020 | 24 | 62 | $4,334 | $3,375 | 77.9% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 39 | 39 | $3,588 | $2,679 | 74.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 16 | $2,075 | $1,566 | 75.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 28 | $1,549 | $1,231 | 79.5% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2020 | 17 | 20 | $1,391 | $1,097 | 78.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 28 | 56 | $81.36 | $64.36 | 79.1% |
About Igor Beneditskiy, MD, DO
Igor Beneditskiy, MD, DO is a Neuromusculoskeletal Medicine & OMM healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043396047.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Igor Beneditskiy, MD, DO has received a total of $1,011 in payments from pharmaceutical and medical device companies, with $17.19 received in 2023. These payments were reported across 54 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($957.33).
As a Medicare-enrolled provider, Beneditskiy has provided services to 888 Medicare beneficiaries, totaling 2,032 services with total Medicare billing of $129,526. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Other Specialties Family Medicine
- Location Brooklyn, NY
- Active Since 10/31/2006
- Last Updated 08/03/2022
- Taxonomy Code 204D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043396047
Products in Payments
- Horizant (Drug) $249.14
- NUEDEXTA (Drug) $170.26
- NASCOBAL (Drug) $92.55
- NUPLAZID (Drug) $85.48
- RYTARY (Drug) $70.21
- Aimovig (Biological) $67.58
- LINZESS (Drug) $47.20
- CREON (Drug) $44.92
- AMPYRA (Drug) $35.35
- iFuse Implant (Device) $25.78
- Gralise (Drug) $25.00
- VIMOVO (Drug) $18.48
- INBRIJA (Drug) $18.18
- VIBERZI (Drug) $17.19
- NAMZARIC (Drug) $16.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neuromusculoskeletal Medicine & OMM Doctors in Brooklyn
Dr. Leonid Tafler
Neuromusculoskeletal Medicine & OMM — Payments: $1,747
Neuromusculoskeletal Medicine & OMM $1,747
Firdous Rizvi, Md, MD
Neuromusculoskeletal Medicine & OMM — Payments: $136.35
Neuromusculoskeletal Medicine & OMM $136.35
Dr. Ben Taylor, D.o, D.O
Neuromusculoskeletal Medicine & OMM — Payments: $124.80
Neuromusculoskeletal Medicine & OMM $124.80
Ernesto Henderson, Do, DO
Neuromusculoskeletal Medicine & OMM — Payments: $43.00
Neuromusculoskeletal Medicine & OMM $43.00
Dr. Douglas Weston, D.o, D.O
Neuromusculoskeletal Medicine & OMM
Neuromusculoskeletal Medicine & OMM
Dr. Jonathan Perk, M.d. Ph.d, M.D. PH.D
Neuromusculoskeletal Medicine & OMM
Neuromusculoskeletal Medicine & OMM